Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The compromised host.

R Feld1

  • 1University of Toronto, Ontario, Canada.

European Journal of Cancer & Clinical Oncology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

This review covers infections in immunocompromised hosts, detailing predisposing factors and susceptibility to various infections. It serves as an introduction to specific immunocompromised conditions discussed further.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review.

Current oncology (Toronto, Ont.)·2015
Same author

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.

Lung cancer (Amsterdam, Netherlands)·2014
Same author

A case of recurrent metastatic ameloblastoma and hypercalcaemia successfully treated with carboplatin and paclitaxel: long survival and prolonged stable disease.

Ecancermedicalscience·2013
Same author

Multicentre Canadian clinical trials on neutropenic patients.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

Area of Science:

  • Infectious Diseases
  • Immunology

Background:

  • Immunocompromised hosts are at increased risk of diverse infections.
  • Underlying diseases and external factors significantly influence infection susceptibility.

Purpose of the Study:

  • To provide a comprehensive overview of infections in all types of immunocompromised hosts.
  • To identify predisposing factors and explain the rationale behind specific infection risks.

Main Methods:

  • Literature review of infections in immunocompromised individuals.
  • Analysis of predisposing conditions and infection types.

Main Results:

  • Detailed examination of factors contributing to infection risk.
  • Categorization of infections based on host immune status.

Conclusions:

  • Understanding predisposing factors is crucial for managing infections in immunocompromised patients.
  • This review sets the stage for in-depth discussions on specific immunocompromised populations.